Mouse Anti-HDAC4 Recombinant Antibody (CBT671) (V2LY-0625-LY3354)

Name: Mouse Anti-HDAC4 Recombinant Antibody (CBT671)
SKU: V2LY-0625-LY3354
Rating: 5 (1 reviews)

See all HDAC4 antibodies

Compare Online Inquiry

Tested Data

Mouse Anti-HDAC4 Recombinant Antibody (CBT671) (V2LY-0625-LY3354) in WB

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

CBT671

Application

WB, ELISA

Immunogen

Purified recombinant fragment of human HDAC4 expressed in E. Coli.

Host Species

Mouse

Specificity

Human

Antibody Isotype

IgG

Clonality

Monoclonal Antibody

Application Notes

Application	Note
ELISA	1:10,000
WB	1:500-1:2,000

Formulations & Storage [For reference only, actual COA shall prevail!]

Format

Supernatant

Buffer

BSA, Glycerol

Preservative

Sodium azide

Concentration

Batch dependent

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

More Infomation

Target

Full Name

Histone Deacetylase 4

Entrez Gene ID

9759

UniProt ID

P56524

Function

Responsible for the deacetylation of lysine residues on the N-terminal part of the core histones (H2A, H2B, H3 and H4). Histone deacetylation gives a tag for epigenetic repression and plays an important role in transcriptional regulation, cell cycle progression and developmental events. Histone deacetylases act via the formation of large multiprotein complexes. Involved in muscle maturation via its interaction with the myocyte enhancer factors such as MEF2A, MEF2C and MEF2D. Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer. Deacetylates HSPA1A and HSPA1B at 'Lys-77' leading to their preferential binding to co-chaperone STUB1 (PubMed:27708256).

Biological Process

B cell activation Source: UniProtKB
B cell differentiation Source: UniProtKB
Cardiac muscle hypertrophy in response to stress Source: BHF-UCL
Chromatin remodeling Source: BHF-UCL
Histone deacetylation Source: BHF-UCL
Histone H3 deacetylation Source: BHF-UCL
Histone H4 deacetylation Source: BHF-UCL
Inflammatory response Source: UniProtKB
Negative regulation of DNA-binding transcription factor activity Source: BHF-UCL
Negative regulation of glycolytic process Source: BHF-UCL
Negative regulation of myotube differentiation Source: BHF-UCL
Negative regulation of transcription, DNA-templated Source: BHF-UCL
Negative regulation of transcription by RNA polymerase II Source: BHF-UCL
Nervous system development Source: UniProtKB
Peptidyl-lysine deacetylation Source: BHF-UCL
Positive regulation of cell population proliferation Source: BHF-UCL
Positive regulation of DNA-binding transcription factor activity Source: BHF-UCL
Positive regulation of protein sumoylation Source: UniProtKB
Positive regulation of transcription, DNA-templated Source: BHF-UCL
Positive regulation of transcription by RNA polymerase II Source: BHF-UCL
Protein deacetylation Source: UniProtKB
Regulation of gene expression, epigenetic Source: UniProtKB
Regulation of protein binding Source: BHF-UCL
Response to denervation involved in regulation of muscle adaptation Source: BHF-UCL
Response to interleukin-1 Source: BHF-UCL

Cellular Location

Nucleus; Cytoplasm. Shuttles between the nucleus and the cytoplasm. Upon muscle cells differentiation, it accumulates in the nuclei of myotubes, suggesting a positive role of nuclear HDAC4 in muscle differentiation. The export to cytoplasm depends on the interaction with a 14-3-3 chaperone protein and is due to its phosphorylation at Ser-246, Ser-467 and Ser-632 by CaMK4 and SIK1. The nuclear localization probably depends on sumoylation. Interaction with SIK3 leads to HDAC4 retention in the cytoplasm (By similarity).

Involvement in disease

Brachydactyly-mental retardation syndrome (BDMR):
The gene represented in this entry is involved in disease pathogenesis. HDAC4 point mutations and chromosomal microdeletions encompassing this gene have been found in BDMR patients (PubMed:20691407, PubMed:24715439, PubMed:23188045). However, HDAC4 haploinsufficiency is not fully penetrant and multiple genes may contribute to manifestation of the full phenotypic spectrum (PubMed:24715439, PubMed:23188045). A syndrome resembling the physical anomalies found in Albright hereditary osteodystrophy. Common features are mild facial dysmorphism, congenital heart defects, distinct brachydactyly type E, mental retardation, developmental delay, seizures, autism spectrum disorder, and stocky build. Soft tissue ossification is absent, and there are no abnormalities in parathyroid hormone or calcium metabolism.

PTM

Phosphorylated by CaMK4 at Ser-246, Ser-467 and Ser-632. Phosphorylation at other residues by CaMK2D is required for the interaction with 14-3-3. Phosphorylation at Ser-350, within the PxLPxI/L motif, impairs the binding of ANKRA2 but generates a high-affinity docking site for 14-3-3.
Sumoylation on Lys-559 is promoted by the E3 SUMO-protein ligase RANBP2, and prevented by phosphorylation by CaMK4.

Macabuag, N., Esmieu, W., Breccia, P., Jarvis, R., Blackaby, W., Lazari, O., ... & Dominguez, C. (2022). Developing HDAC4-selective protein degraders to investigate the role of HDAC4 in Huntington’s disease pathology. Journal of Medicinal Chemistry, 65(18), 12445-12459.

Huang, C., Lin, Z., Liu, X., Ding, Q., Cai, J., Zhang, Z., ... & Zhu, Y. Z. (2022). HDAC4 Inhibitors as Antivascular Senescence Therapeutics. Oxidative Medicine and Cellular Longevity, 2022.

Cheng, C., Yang, J., Li, S. W., Huang, G., Li, C., Min, W. P., & Sang, Y. (2021). HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target. Cell Death & Disease, 12(2), 137.

Federspiel, J. D., Greco, T. M., Lum, K. K., & Cristea, I. M. (2019). Hdac4 interactions in Huntington's disease viewed through the prism of multiomics. Molecular & Cellular Proteomics, 18(8), S92-S113.

Jin, K., Zhao, W., Xie, X., Pan, Y., Wang, K., & Zhang, H. (2018). MiR‐520b restrains cell growth by targeting HDAC4 in lung cancer. Thoracic cancer, 9(10), 1249-1254.

Maddox, S. A., Kilaru, V., Shin, J., Jovanovic, T., Almli, L. M., Dias, B. G., ... & Smith, A. K. (2018). Estrogen-dependent association of HDAC4 with fear in female mice and women with PTSD. Molecular psychiatry, 23(3), 658-665.

Yang, D., Xiao, C., Long, F., Su, Z., Jia, W., Qin, M., ... & Zhu, Y. (2018). HDAC4 regulates vascular inflammation via activation of autophagy. Cardiovascular research, 114(7), 1016-1028.

Kong, Q., Hao, Y., Li, X., Wang, X., Ji, B., & Wu, Y. (2018). HDAC4 in ischemic stroke: mechanisms and therapeutic potential. Clinical epigenetics, 10, 1-9.

Hou, F., Wei, W., Qin, X., Liang, J., Han, S., Han, A., & Kong, Q. (2020). The posttranslational modification of HDAC4 in cell biology: mechanisms and potential targets. Journal of Cellular Biochemistry, 121(2), 930-937.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-HDAC4 Recombinant Antibody (CBT671)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-HDAC4 Recombinant Antibody (4A3-H7-C6) (CAT#: CBMAB-Z0262-LY)

Rabbit Anti-HDAC4 (AA 568-585,147-163) Recombinant Antibody (14H4L10) (CAT#: CBMAB-H1782-FY)

Mouse Anti-HDAC4 Recombinant Antibody (CAP889) (CAT#: CBMAB-AP2690LY)

Mouse Anti-HDAC4 Recombinant Antibody (CAP888) (CAT#: CBMAB-AP2689LY)

Mouse Anti-HDAC4 (AA 529-651 ) Recombinant Antibody (14A9C47) (CAT#: CBMAB-H1781-FY)

Mouse Anti-HDAC4 Recombinant Antibody (CAP887) (CAT#: CBMAB-AP2688LY)

Rabbit Anti-HDAC4 Recombinant Antibody (D15C3) (CAT#: CBMAB-H1784-FY)

Mouse Anti-HDAC4 Recombinant Antibody (7B2) (CAT#: CBMAB-AO553LY)

Mouse Anti-HDAC4 Recombinant Antibody (CB405A) (CAT#: CBMAB-CA405LY)

Mouse Anti-HDAC4 (AA 551-648) Recombinant Antibody (CBFYH-0871) (CAT#: CBMAB-H1792-FY)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry